# Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases

> **NCT00489697** · NA · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 200 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DEVICE:** real-time contrast-enhanced ultrasound imaging (CEUS)

## Key facts

- **NCT ID:** NCT00489697
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489697, "Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00489697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*